AiVita Biomedical Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$6.05M
- Investors
-
11
AiVita Biomedical General Information
Description
Operator of a biotechnology company intended for the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. The company offers personalized vaccines for the prevention of infectious diseases and the treatment of cancer, and the vaccine kit ensures pathogen readiness against emerging and evolving threats, enabling the medical systems to bring cell-based therapies and treatments to the patients.
Contact Information
Website
www.aivitabiomedical.comCorporate Office
- 18301 Von Karman Avenue
- Suite 130
- Irvine, CA 92612
- United States
Corporate Office
- 18301 Von Karman Avenue
- Suite 130
- Irvine, CA 92612
- United States
AiVita Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series C) | 30-Aug-2022 | $6.05M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series B2) | 30-Mar-2022 | Completed | Generating Revenue | |||
| 4. Grant | 17-Jul-2018 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 11-Jun-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 13-Mar-2018 | $5.5M | $5.5M | Completed | Clinical Trials - Phase 2 | |
| 1. Grant | 29-Sep-2016 | $22M | Completed | Clinical Trials - Phase 2 |
AiVita Biomedical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B-2 | ||||||||
| Series B | 1,638,123 | $0.001000 | 8% | $12 | $12 | 1x | $12 | 15.35% |
| Series A | 994,218 | $0.001000 | 8% | $6.27 | $6.27 | 1x | $6.27 | 9.32% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AiVita Biomedical Comparisons
Industry
Financing
Details
AiVita Biomedical Competitors (85)
One of AiVita Biomedical’s 85 competitors is Centrose, a Venture Capital-Backed company based in Madison, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| Hummingbird Bioscience | Venture Capital-Backed | Singapore, Singapore | ||||
| Iovance Biotherapeutics | Corporation | San Carlos, CA | ||||
| Sorrento Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Meditope Biosciences | Formerly VC-backed | Pasadena, CA |
AiVita Biomedical Patents
AiVita Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021284302-A1 | Autologous dendritic cell vaccine kit and uses | Pending | 02-Jun-2020 | ||
| CA-3184883-A1 | Autologous dendritic cell vaccine kit and uses | Pending | 02-Jun-2020 | ||
| EP-4157340-A1 | Autologous dendritic cell vaccine kit and uses | Pending | 02-Jun-2020 | ||
| EP-4157340-A4 | Autologous dendritic cell vaccine kit and uses | Pending | 02-Jun-2020 | ||
| US-20230210982-A1 | Autologous dendritic cell vaccine kit and uses | Pending | 02-Jun-2020 | A61K39/215 |
AiVita Biomedical Signals
AiVita Biomedical Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| JLS Fund | Venture Capital | Minority | ||
| Big Sky Partners | Venture Capital | Minority | ||
| Ci:z Investment | Corporate Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| SDV Holdings | Venture Capital | Minority |
AiVita Biomedical FAQs
-
When was AiVita Biomedical founded?
AiVita Biomedical was founded in 2016.
-
Where is AiVita Biomedical headquartered?
AiVita Biomedical is headquartered in Irvine, CA.
-
What is the size of AiVita Biomedical?
AiVita Biomedical has 20 total employees.
-
What industry is AiVita Biomedical in?
AiVita Biomedical’s primary industry is Biotechnology.
-
Is AiVita Biomedical a private or public company?
AiVita Biomedical is a Private company.
-
What is the current valuation of AiVita Biomedical?
The current valuation of AiVita Biomedical is .
-
What is AiVita Biomedical’s current revenue?
The current revenue for AiVita Biomedical is .
-
How much funding has AiVita Biomedical raised over time?
AiVita Biomedical has raised $53.5M.
-
Who are AiVita Biomedical’s investors?
JLS Fund, Big Sky Partners, Ci:z Investment, , and SDV Holdings are 5 of 11 investors who have invested in AiVita Biomedical.
-
Who are AiVita Biomedical’s competitors?
Centrose, Hummingbird Bioscience, Iovance Biotherapeutics, Sorrento Therapeutics, and Meditope Biosciences are some of the 85 competitors of AiVita Biomedical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process